(Q24240765)

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Sequential computerized tomographic appearance of strokes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Anticoagulant therapy in acute cerebrovascular accidents. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Anticoagulant therapy in cerebral infarction. Report on cooperative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Trial of long-term anticoagulant therapy in the treatment of small stroke associated with a normal carotid arteriogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

A long-term study of cerebral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

A cooperative study of cerebrovascular disease; methodology and a preliminary report on the use of anticoagulants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Guidelines for the Early Management of Adults With Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Use of intravenous heparin by North American neurologists: do the data matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Statistics notes. Interaction 1: Heterogeneity of effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Complications after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Stroke epidemiology in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Fibrinogen depleting agents for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Antithrombotic drugs for carotid artery dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Thrombolysis for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Anticoagulants for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

Deep vein thrombosis: prevention in stroke patients during rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

[Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients)]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

[Prevention of venous thrombosis in recent ischaemic cerebrovascular accident: double-blind study with heparin-dihydroergotamine (author's transl)]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Thrombin inhibition in the acute phase of ischaemic stroke using argatroban

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Anticoagulant treatment in progressing stroke.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Anticoagulant therapy in cerebral thrombosis and cerebral embolism. A national cooperative study, interim report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease. Report of the Veterans Administration Cooperative Study of Atherosclerosis, Neruology Section

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Use of anticoagulants in patients with progressive cerebral infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Intravenous heparin for the prevention of stroke progression in acute partial stable stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021

Heparin in acute partial stable stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000024.PUB3

7 January 2021